85 related articles for article (PubMed ID: 23242280)
21. Efficacy of Sulforaphane in Neurodegenerative Diseases.
Schepici G; Bramanti P; Mazzon E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207780
[TBL] [Abstract][Full Text] [Related]
22. Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases.
Scuderi SA; Ardizzone A; Paterniti I; Esposito E; Campolo M
Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32708926
[TBL] [Abstract][Full Text] [Related]
23.
Matthews DG; Caruso M; Murchison CF; Zhu JY; Wright KM; Harris CJ; Gray NE; Quinn JF; Soumyanath A
Antioxidants (Basel); 2019 Dec; 8(12):. PubMed ID: 31817977
[No Abstract] [Full Text] [Related]
24. Anti-Diabetic Countermeasures Against Tobacco Smoke-Dependent Cerebrovascular Toxicity: Use and Effect of Rosiglitazone.
Sivandzade F; Cucullo L
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470514
[TBL] [Abstract][Full Text] [Related]
25. Cerebrovascular and Neurological Disorders: Protective Role of NRF2.
Sivandzade F; Bhalerao A; Cucullo L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336872
[TBL] [Abstract][Full Text] [Related]
26. Basic Concepts on the Role of Nuclear Factor Erythroid-Derived 2-Like 2 (Nrf2) in Age-Related Diseases.
Francisqueti-Ferron FV; Ferron AJT; Garcia JL; Silva CCVA; Costa MR; Gregolin CS; Moreto F; Ferreira ALA; Minatel IO; Correa CR
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261912
[TBL] [Abstract][Full Text] [Related]
27. Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood-brain barrier impairment.
Sivandzade F; Cucullo L
BMC Neurosci; 2019 Apr; 20(1):15. PubMed ID: 30947684
[TBL] [Abstract][Full Text] [Related]
28. Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders.
Vasconcelos AR; Dos Santos NB; Scavone C; Munhoz CD
Front Pharmacol; 2019; 10():33. PubMed ID: 30778297
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
Bahn G; Jo DG
Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
[TBL] [Abstract][Full Text] [Related]
30. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
31. Non-canonical activation of NRF2: New insights and its relevance to disease.
Dodson M; Zhang DD
Curr Pathobiol Rep; 2017 Jun; 5(2):171-176. PubMed ID: 29082113
[TBL] [Abstract][Full Text] [Related]
32. Unhealthy smokers: scopes for prophylactic intervention and clinical treatment.
Prasad S; Kaisar MA; Cucullo L
BMC Neurosci; 2017 Oct; 18(1):70. PubMed ID: 28985714
[TBL] [Abstract][Full Text] [Related]
33. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?
Liddell JR
Antioxidants (Basel); 2017 Aug; 6(3):. PubMed ID: 28820437
[TBL] [Abstract][Full Text] [Related]
34. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
Tönnies E; Trushina E
J Alzheimers Dis; 2017; 57(4):1105-1121. PubMed ID: 28059794
[TBL] [Abstract][Full Text] [Related]
35. Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases.
Sun Y; Yang T; Leak RK; Chen J; Zhang F
CNS Neurol Disord Drug Targets; 2017; 16(3):326-338. PubMed ID: 28042770
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Keap1/Nrf2 stress response pathway in autophagic vacuolar myopathies.
Duleh S; Wang X; Komirenko A; Margeta M
Acta Neuropathol Commun; 2016 Oct; 4(1):115. PubMed ID: 27799074
[TBL] [Abstract][Full Text] [Related]
37. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling.
Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R
Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286
[TBL] [Abstract][Full Text] [Related]
38. Redox-based therapeutics in neurodegenerative disease.
McBean GJ; López MG; Wallner FK
Br J Pharmacol; 2017 Jun; 174(12):1750-1770. PubMed ID: 27477685
[TBL] [Abstract][Full Text] [Related]
39. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.
Loboda A; Damulewicz M; Pyza E; Jozkowicz A; Dulak J
Cell Mol Life Sci; 2016 Sep; 73(17):3221-47. PubMed ID: 27100828
[TBL] [Abstract][Full Text] [Related]
40. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
